By day 28, 70% of recipients of remdesivir plus standard care and 53% who received standard care alone had been released from the hospital, a 16% difference.
Remdesivir tied to 54% lower risk of death among hospitalized COVID patients
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Genetic vulnerability, air pollution may raise risk of COVID infection, severe outcomes
- COVID 2024-25 vaccines 33% protective against emergency room or urgent care visits, data reveal
- Paxlovid may better cut risk of severe COVID outcomes in asthma patients than molnupiravir
- US flu season shows signs of peak